If you missed our online fundraiser deadline of Nov. 18, you can still help change the future of cancer treatments by going to this link and making your tax deductible donation today!
NEWS FLASH! Private Foundation* offers $10k challenge grant. They will match every dollar donated to our indiegogo campaign, up to a maximum of $10,000 (US). Please donate today and help us take advantage of this exciting challenge grant!
special thanks to the Shearer Family Foundation for this Challenge Grant!
STOP THE SUFFERING OF CHILDREN WITH CANCER
Toxic drug and radiation treatments for cancer don't have to be the only choices!
We have a better and nontoxic way!
Skidmore College Professor Anthony Holland discovered a new nontoxic way to destroy cancer cells using oscillating pulsed electric fields (OPEF), astounding the cancer experts, but because this new method does not use toxic drugs , it's impossible to move the research work forward without your help! [Big Pharma supports most cancer research which is based on finding the next toxic drug that can be patented!]
We are at a critical juncture in our research work and not one penny you give will go toward administrative expenses because all of our laboratory workers are volunteers, dedicated to developing what we believe will be the cancer therapy of the future!
Help us break the stranglehold BIG PHARMA has over truly innovative cancer research by helping us purchase vital laboratory equipment!
See Part of The Documentary Film-in-progress about our work entitled "The Cure" (click here to watch)
In 2009-10, I was invited to work for four months in a major cancer research laboratory in Philadelphia (Thomas Jefferson University Medical School [TJU], Department of Surgical Research) to test a theory I had that oscillating pulsed electric fields (OPEF) could destroy cancer cells.
CLICK HERE TO SEE THE TJU SURGICAL NEWSLETTER WITH A FEATURE STORY ON OUR EXPERIMENTS IN THEIR CANCER RESEARCH LABS.
The top cancer experts in the lab were utterly astonished when my experiments worked and killed 30% of cancerous leukemia cells in repeated experiments! Their top lab techs also noted we had slowed the growth of the cancer by as much as 60%. They'd never seen anything like it!
The cancer experts said: "if this had been a multimillion dollar drug developed by 'Big Pharma', this would have been considered a 'home run'!" But this discovery was funded out of pocket by Professor Holland personally, not by a large grant or organization, AND because it is not a drug based method to kill cancer cells, there is a kind of 'Berlin Wall' we cannot break through to continue our cancer research.
BIG PHARMA supplies hundreds of millions of dollars to major cancer research centers around the world to develop ever more toxic drugs that leave the patient almost wishing for death, but no funding for small companies that have discovered a non drug approach to cancer, so we are turning to you, the public, to help us break Big Pharma's stranglehold over truly innovative cancer research!
WHERE WILL THE MONEY GO?
These are the key pieces of equipment needed to move our discovery to the next stage:
$12,000 Biosafety Cabinet
$10,000 CO2 incubator
$3,000 Inverted Microscope
$2,000 Labware & Supplies
(above)The lower of two pancreatic cancer cells is gradually shattered in one of our experiments in 2010.
Here's the dream YOU can help make a reality:
A group of children suffering from cancer enter a pleasant new kind of 'play room' and make new friends. They watch TV, read a book, play their video game, or just chat with their new friends... all the while not even knowing that painless and nontoxic pulsed electric fields are flowing throughout the room and gradually destroying their cancer cells. They don't feel sick. Their hair does not fall out and they never even realize they are receiving a new medical treatment, the cancer treatment of the future!
Our Volunteer Team of Experts:
Anthony Holland: Associate Professor, Director of Music Technology, Skidmore College. DMA, MM, MM, BM; President: Novobiotronics Inc. [a nonprofit 501(c)(3) charitable and educational company]. Discovered the ability of Oscillating Pulsed Electric Fields (OPEF) to destroy cancer cells in laboratory experiments. Expert in custom digital electronic signal design, synthesis and analysis for biological effects. Member: Bioelectromagnetics Society (BEMS), European Bioelectromagnetics Association (EBEA). Postdoctoral work: Center for Computer Research in Music and Acoustics (CCRMA) Stanford University. Advanced Digital Synthesis and Analysis studies with: Max Mathews (the ' Father of Computer Music'), John Chowning (founding Director of CCRMA, Electronic Composer and Inventor (famed FM Synthesis Patent); Jean-Claude Risset (Electronic Composer and founding Director of the Digital Synthesis Division of the internationally renowned IRCAM center, Paris, France); John Pierce: former Director of Sound Division: Bell Laboratories.
Dr. James Bare: Chiropractic Physician, Inventor, specialist in therapeutic pulsed electromagnetic device research and development, member of the New York Academy of Sciences and the Bioelectromagnetics Society.
Phillip Ortiz: PhD (Physiology and Biophysics) expert in cell biology, molecular biology and tissue culture research and assay techniques. He is a fellow of the American Diabetes Association and the National Institutes of Health. Coordinator of Science Education, State University of New York (SUNY), Empire State College.
Holly Ahern: Associate Professor of Microbiology, Director of Microbiology Research: State University of New York (SUNY) Adirondack. Director: Center for Lyme Disease Education and Research. [Graduate research lab technician experience in cell assay techniques, Albany Medical College].
Gérard Dubost, PhD (University of Paris, France): Physicist, Plasma Physics expert & Electrical Engineer. Numerous published papers and international presentations on the biological effects of electromagnetic fields and pulsed plasmas. Professor Emeritus University of Rennes, Institute of Electronics and Telecommunications, Rennes (IETR).